SexAnnoDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Gene structure and Gene expression level

leaf

Sex-biased somatic mutation

leaf

DNA methylation with beta values in gene

leaf

Exon skipping events with PSI in TCGA

leaf

RNA A-to-I editing events in TCGA

leaf

Sex-biased TF-Gene network of gene

leaf

Sex-biased RBP-ES network of gene

leaf

Sex-biased CeRNA regulation of gene

leaf

Sex-biased eQTL regulation of gene

leaf

Sex-biased eQTM regulation of gene

leaf

Sex-biased sQTL regulation of gene

leaf

Sex-biased sQTM regulation of gene

leaf

Related disease information of gene

Gene: ENSG00000112715

Summary for VEGFA

check button Gene summary

Gene informationEnsembl ID

ENSG00000112715

Gene symbol

VEGFA

Gene namevascular endothelial growth factor A
HGNC

12680

Entrez ID

7422

Gene typeprotein_coding
SynonymsVEGFA|VEGF-A|VPF
UniProtAcc

P15692


check buttonDrugs associated with this gene(DrugBank).
Gene IDGene SymbolDrug IDDrug NameDrug Type
ENSG00000112715VEGFADB00112BevacizumabBiotechDrug
ENSG00000112715VEGFADB01017MinocyclineSmallMoleculeDrug
ENSG00000112715VEGFADB01120GliclazideSmallMoleculeDrug
ENSG00000112715VEGFADB01136CarvedilolSmallMoleculeDrug
ENSG00000112715VEGFADB01270RanibizumabBiotechDrug
ENSG00000112715VEGFADB03088Pidolic acidSmallMoleculeDrug
ENSG00000112715VEGFADB04895PegaptanibBiotechDrug
ENSG00000112715VEGFADB05294VandetanibSmallMoleculeDrug
ENSG00000112715VEGFADB05434ABT-510SmallMoleculeDrug
ENSG00000112715VEGFADB05890VeglinSmallMoleculeDrug
ENSG00000112715VEGFADB05932DenibulinSmallMoleculeDrug
ENSG00000112715VEGFADB05969SNS-032SmallMoleculeDrug
ENSG00000112715VEGFADB06642BevasiranibBiotechDrug
ENSG00000112715VEGFADB06779DalteparinSmallMoleculeDrug
ENSG00000112715VEGFADB08885AfliberceptBiotechDrug
ENSG00000112715VEGFADB09301Chondroitin sulfateSmallMoleculeDrug
ENSG00000112715VEGFADB10772Foreskin keratinocyte (neonatal)BiotechDrug
ENSG00000112715VEGFADB14864BrolucizumabBiotechDrug
ENSG00000112715VEGFADB15303FaricimabBiotechDrug

check buttonCancer therapeutic drugs associated with this gene(NCI).
Gene IDGene NameDrug IDDrug NameDrug TypeCancer
ENSG00000112715VEGFADB00112BevacizumabBiotechDrugBrain Tumors,Treat Cervical Cancer,Colon Cancer,Rectal Cancer, Renal Cell Cancer (RCC),Non-Small Cell Lung Cancer,Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ENSG00000112715VEGFADB05294VandetanibSmallMoleculeDrugThyroid Cancer
ENSG00000112715VEGFADB08885AfliberceptBiotechDrugColon Cancer,Rectal Cancer

Top

Structure and expression level for VEGFA

check buttonAS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.
∗For more information on exon skipping events please check the ExonskipDB database.
∗For more information on exon skipping events please check the CAeditome database.
UCSC result

check buttonLandscape of gene expressions across multiple cancer types.
gene expression analysis

check buttonDifferentially expressed gene analysis between tumor male and tumor female samples.
Coding NameBase Meanlog2FoldChangelfcSEStatP valueP.adjust ValueCancer Type

check buttonDifferentially expressed gene analysis between tumor male and normal male samples.
DEG result
Coding NameBase Meanlog2FoldChangelfcSEStatP valueP.adjust ValueCancer Type
VEGFA7.87e+031.03e+001.73e-015.92e+003.32e-091.80e-08HNSC

check buttonDifferentially expressed gene analysis between tumor female and normal female samples.
DEG result
Coding NameBase Meanlog2FoldChangelfcSEStatP valueP.adjust ValueCancer Type
VEGFA6.47e+032.03e+002.77e-017.31e+002.71e-131.45e-11READ

Top

Sex-biased somatic mutation for VEGFA

∗For more information on exon skipping events please check the ExonskipDB database.
Gene IDCancer TypeHugo SymbolMaleFemalepvalorci.upci.lowadjPval

Top

DNA methylation with beta values for VEGFA

check buttonLandscape of DNA methylation across multiple cancer types.
methylation heatmap

check buttonDifferentially expressed CpG sites between male tumor and female tumor patients.
Cancer TypeCpG SitePositionCpG IslandPosition to Geneave1ave2wilcoxon.wwilcoxon.ppadjdBeta

check buttonDifferentially expressed CpG sites between male tumor and male normal patients.
Cancer TypeCpG SitePositionCpG IslandPosition to Geneave1ave2wilcoxon.wwilcoxon.ppadjdBeta
BLCAcg00539360chr6:43769399CGI:chr6:43769895-43772115promoter6.83e-015.68e-012.91e+003.64e-036.32e-031.15e-01
ESCAcg18022921chr6:43769236CGI:chr6:43769895-43772115promoter6.28e-015.22e-012.48e+001.31e-023.74e-021.06e-01

check buttonDifferentially expressed CpG sites between female tumor and female normal patients.
Cancer TypeCpG SitePositionCpG IslandPosition to Geneave1ave2wilcoxon.wwilcoxon.ppadjdBeta
BRCAcg01298514chr6:43769070CGI:chr6:43769895-43772115promoter7.84e-014.93e-011.38e+013.14e-436.17e-412.91e-01
BRCAcg18022921chr6:43769236CGI:chr6:43769895-43772115promoter6.77e-013.76e-011.39e+018.61e-442.12e-413.02e-01
BRCAcg00539360chr6:43769399CGI:chr6:43769895-43772115promoter6.87e-014.50e-011.36e+013.16e-424.45e-402.37e-01

Top

Exon skipping events with PSI in TCGA for VEGFA

∗Please access ExonSkipDB for exon skipping annotation.
check buttonLandscape of exon skipping events across multiple cancer types.
AS event heatmap

check buttonDifferentially expressed exon skipping events between male tumor and female tumor patients.
Cancer TypeExon Skippingave.female_Tave.female_Nwilcoxon.wwilcoxon.ppadjdPSI

check buttonDifferentially expressed exon skipping events between male tumor and male normal patients.
Cancer TypeExon Skippingave.female_Tave.female_Nwilcoxon.wwilcoxon.ppadjdPSI
HNSCexon_skip_4522434.15e-015.22e-01-4.41e+001.01e-051.05e-04-1.07e-01
CHOLexon_skip_4522434.31e-016.01e-01-3.11e+001.85e-031.21e-02-1.70e-01

check buttonDifferentially expressed exon skipping events between female tumor and female normal patients.
Cancer TypeExon Skippingave.female_Tave.female_Nwilcoxon.wwilcoxon.ppadjdPSI
BLCAexon_skip_4522434.56e-015.62e-01-2.81e+004.98e-032.32e-02-1.06e-01

Top

RNA A-to-I editing events in TCGA for VEGFA

∗Please access CAeditome for RNA editing annotation.
check buttonDifferentially expressed RNA editing events between male tumor and female tumor patients.
Cancer TypeTranscriptEditingave.male_Tave.female_Twilcoxon.wwilcoxon.pp_adjdFre

check buttonDifferentially expressed RNA editing events between male tumor and male normal patients.
Cancer TypeTranscriptEditingave.male_Tave.female_Twilcoxon.wwilcoxon.pp_adjdFre

check buttonDifferentially expressed RNA editing events between female tumor and female normal patients.
Cancer TypeTranscriptEditingave.male_Tave.female_Twilcoxon.wwilcoxon.pp_adjdFre

check buttonProtein coding RNA editing(s).
Editing PositionVariant TypeGene SymbolTranscript IDNTchangeAAchange

Top

Sex-biased TF-Gene network for VEGFA

check buttonTFs related to VEGFA.
∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98.
∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98.
TF Gene
Cancer TypeTFTarget GeneMale Edge ScoreMale Edge ThresholdFemale Edge ScoreFemale Edge ThresholdType
SKCMSRYVEGFA3.49e+006.87e-034.59e+009.81e-01Female-biased
SKCMZNF418VEGFA1.90e+002.65e-054.61e+009.89e-01Female-biased

check buttonVEGFA related gene.
∗Only the gene encode TF might with this result.
∗For more information please check Sex-biased TF-Coding gene network.

Top

Sex-biased RBP-ES network for VEGFA

check buttonRBPs related to ES in VEGFA.
∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98.
∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98.
RBP ES
Cancer TypeRBPTarget ESMale Edge ScoreMale Edge ThresholdFemale Edge ScoreFemale Edge ThresholdType
THYMNOVA2exon_skip_4522159.63e+009.86e-019.32e+001.09e-02Male-biased
READIGF2BP2exon_skip_4522437.97e+009.80e-017.64e+001.10e-02Male-biased
READIGF2BP3exon_skip_4522437.99e+009.80e-017.67e+001.12e-02Male-biased
PCPGZFP36exon_skip_4522296.69e+003.30e-037.10e+009.84e-01Female-biased
MESOZFP36exon_skip_4522326.54e+009.81e-015.97e+001.25e-03Male-biased

check buttonVEGFA related ES.
∗Only the gene encode RBP might with this result.
∗For more information please check Sex-biased RBP-ES network in cancer.

Top

Sex-biased CeRNA regulation of gene

check buttonSex-biased CeRNA regulation of gene.
Gene IDceRNA(lncRNA-miRNA-mRNA)GroupCancer Type
ENSG00000112715Z95331.1,hsa-mir-106a,VEGFAMale-specific ceRNATCGA-HNSC
ENSG00000112715AC083843.2,hsa-mir-106a,VEGFAMale-specific ceRNATCGA-HNSC
ENSG00000112715CARS1-AS1,hsa-mir-205,VEGFAMale-specific ceRNATCGA-HNSC
ENSG00000112715AC083843.2,hsa-mir-205,VEGFAMale-specific ceRNATCGA-HNSC
ENSG00000112715CASK-AS1,hsa-mir-206,VEGFAMale-specific ceRNATCGA-HNSC
ENSG00000112715AC078795.1,hsa-mir-206,VEGFAMale-specific ceRNATCGA-HNSC
ENSG00000112715Z95331.1,hsa-mir-20b,VEGFAMale-specific ceRNATCGA-HNSC
ENSG00000112715AL356299.2,hsa-mir-497,VEGFAMale-specific ceRNATCGA-HNSC
ENSG00000112715Z95331.1,hsa-mir-497,VEGFAMale-specific ceRNATCGA-HNSC
ENSG00000112715Z95331.1,hsa-mir-504,VEGFAMale-specific ceRNATCGA-HNSC
ENSG00000112715Z95331.1,hsa-mir-93,VEGFAMale-specific ceRNATCGA-HNSC

Top

Sex-biased eQTL regulation of gene

check buttonSex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).
eQTLDescription

check buttonMale-specific eQTL regulation.
SNP IDSNP InfoPosition to GeneEffect ScoreFDRCancer TypeBiased Type
rs12529279chr6:39204342:G:T-0.2467736826460750.0178557952435308KIRPFemale-baised eQTL
rs11968212chr6:39208610:G:A-0.2467736826460750.0178557952435308KIRPFemale-baised eQTL
rs236431chr6:36763020:A:G-0.1505872257906330.0379156801053068KIRPFemale-baised eQTL
rs3822969chr6:36752981:G:A-0.1914261074377381.74853807148869e-05LUSCFemale-baised eQTL
rs78905441chr6:42628151:G:T-0.1865747845844984.48821555764035e-05LUSCFemale-baised eQTL
rs4714616chr6:42648704:T:G-0.1865747845844984.48821555764035e-05LUSCFemale-baised eQTL
rs7771830chr6:42534951:G:A-0.1775069449403578.34239729231831e-05LUSCFemale-baised eQTL
rs78720743chr6:36751933:G:A-0.1621658248149660.000527971906541671LUSCFemale-baised eQTL
rs58298156chr6:36752327:G:A-0.1621658248149660.000527971906541671LUSCFemale-baised eQTL
rs59800485chr6:36752465:C:T-0.1621658248149660.000527971906541671LUSCFemale-baised eQTL
rs10484912chr6:42646106:T:C-0.1541341633311850.00193573731862039LUSCFemale-baised eQTL
rs13200755chr6:39184681:G:A-0.1452681422017310.00642006232918236STADFemale-baised eQTL
rs10305525chr6:39088374:C:A-0.06452291373364910.000406879815880136LGGFemale-baised eQTL
rs60678751chr6:39096167:G:A-0.06644745815581090.00128367413387257LGGFemale-baised eQTL
rs2268636chr6:39083699:G:A-0.06656636392032980.00146970821677011LGGFemale-baised eQTL
rs10305516chr6:39086813:C:G-0.06466827489332890.00205021853594387LGGFemale-baised eQTL
rs2268634chr6:39084571:C:G-0.06342833230236410.00263866893199107LGGFemale-baised eQTL
rs2268633chr6:39085217:G:C-0.06326479800033330.00284890213069201LGGFemale-baised eQTL
rs59426516chr6:39116464:G:C-0.05913315811500970.00715324659142179LGGFemale-baised eQTL
rs12665144chr6:39115512:C:T-0.05664902517701020.0130684886819468LGGFemale-baised eQTL
rs12216216chr6:44244415:A:G-0.07829809565567390.0142134189148313LGGFemale-baised eQTL
rs12202977chr6:44244638:G:C-0.07829809565567390.0142134189148313LGGFemale-baised eQTL
rs3757280chr6:44245723:G:C-0.07829809565567390.0142134189148313LGGFemale-baised eQTL
rs9367190chr6:44249917:C:A-0.07823972401466120.0143365182195904LGGFemale-baised eQTL
rs9381303chr6:44249930:C:T-0.07823972401466120.0143365182195904LGGFemale-baised eQTL
rs3187chr6:44254310:G:A-0.07569366470521550.0184911272460121LGGFemale-baised eQTL
rs1570920chr6:44246699:C:G-0.07199811167677280.0238134177689708LGGFemale-baised eQTL
rs2268635chr6:39083918:C:T-0.04816164223238130.026441465123704LGGFemale-baised eQTL
rs9349648chr6:52893686:G:C-0.1661895724895090.0419914501032862KIRCFemale-baised eQTL
rs111352602chr6:36449886:C:T-0.1876055924711810.0206230585406493BLCAFemale-baised eQTL
rs916299chr6:36769815:C:T-0.08198592746178010.0473508148877311COADFemale-baised eQTL
rs916300chr6:36770271:G:A-0.08198592746178010.0473508148877311COADFemale-baised eQTL
rs916302chr6:36770362:T:C-0.08198592746178010.0473508148877311COADFemale-baised eQTL

check buttonFemale-specific eQTL regulation.
SNP IDSNP InfoPosition to GeneEffect ScoreFDRCancer TypeBiased Type
rs76320213chr6:49942310:A:G-0.1447201168171260.0318673331266768PAADMale-baised eQTL
rs78200920chr6:49943243:C:A-0.1447201168171260.0318673331266768PAADMale-baised eQTL
rs12215337chr6:51008328:T:G-0.1086244922489740.01987007501185STADMale-baised eQTL
rs140613663chr6:37031705:T:C-0.1111272272707710.00825620070659045BLCAMale-baised eQTL
rs74539719chr6:37047095:T:C-0.1079943238616730.0103454903357502BLCAMale-baised eQTL
rs115291177chr6:37050340:G:A-0.1079943238616730.0103454903357502BLCAMale-baised eQTL
rs56693599chr6:37049763:A:G-0.1078914741021770.0105138334814066BLCAMale-baised eQTL
rs9382002chr6:51679815:G:C-0.07309162531653710.0119015999371018BLCAMale-baised eQTL
rs77467566chr6:37037850:G:A-0.1035910183032590.0137797190861508BLCAMale-baised eQTL
rs73730518chr6:37038316:G:A-0.1035910183032590.0137797190861508BLCAMale-baised eQTL
rs76878993chr6:37036451:A:G-0.1035181553963890.0138672836155232BLCAMale-baised eQTL
rs76324291chr6:37044702:A:G-0.1035181553963890.0138672836155232BLCAMale-baised eQTL
rs111724721chr6:37044112:G:A-0.1048500342263640.0139881887781296BLCAMale-baised eQTL
rs2475801chr6:39946852:A:G--0.06697145853094320.0148863041313289BLCAMale-baised eQTL
rs4713933chr6:36158201:G:C-0.05797728481426860.0408398491829964BLCAMale-baised eQTL
rs2859133chr6:36148857:C:T-0.05795827059622280.041519880603338BLCAMale-baised eQTL
rs2815807chr6:36144646:C:T-0.05756650541693210.0443342704359957BLCAMale-baised eQTL
rs581216chr6:44911808:T:G-0.1058278862997030.00216260257492788COADMale-baised eQTL
rs3813502chr6:44153479:T:C-0.04555920693898970.0203117795288667COADMale-baised eQTL
rs1041523chr6:44153533:C:T-0.04555920693898970.0203117795288667COADMale-baised eQTL
rs9349413chr6:47543755:A:G--0.0457179631171410.0211454221170157COADMale-baised eQTL
rs302626chr6:39792176:T:C--0.06608958841051290.0232084654614199COADMale-baised eQTL
rs12195738chr6:47615928:C:T--0.04565046374791790.0241781844863424COADMale-baised eQTL
rs2987589chr6:39807458:A:G--0.06929338908905060.0388798864101886COADMale-baised eQTL
rs2767727chr6:51408557:C:T--0.04024538395340790.0478061795932475COADMale-baised eQTL

check buttonOpposite sex-biased eQTL regulation.
SNP IDSNP InfoPosition to GeneMale EffectMale FDRFemale EffectFemale FDRSex-biased Gene in CancerCancer Type

Top

Sex-biased eQTM regulation of gene

check buttonSex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table).
eQTMDescription
eQTM boxplot analysisGene ID: ENSG00000112715
CpG Site: cg25343661
Position to Gene: gene,exon
Male Effect: -0.494970383973877
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000112715
CpG Site: cg18022921
Position to Gene: promoter
Male Effect: -0.494529251402025
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000112715
CpG Site: cg00539360
Position to Gene: promoter
Male Effect: -0.494529251402025
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000112715
CpG Site: cg25343661
Position to Gene: gene,exon
Male Effect: -
Female Effect: -0.443866330293423

check buttonMale-specific eQTM regulation.
CpG SiteCpG PostionPosition to GeneEffect ScoreFDRCor.rCor.PvalueCancer Type
cg25343661chr6:43775444gene,exon-0.4949703839738779.05187929787806e-42-0.79730200298160092.7276053294141042e-45KIRP
cg18022921chr6:43769236promoter-0.4945292514020251.22950824058439e-41-0.78901359734649275.648847445607369e-44KIRP
cg00539360chr6:43769399promoter-0.4945292514020251.22950824058439e-41-0.78901359734649275.648847445607369e-44KIRP

check buttonFemale-specific eQTM regulation.
CpG SiteCpG PostionPosition to GeneEffect ScoreFDRCor.rCor.PvalueCancer Type
cg25343661chr6:43775444gene,exon-0.4438663302934232.9843287004e-08-0.5805197038948146.90933239537667e-11BLCA

check buttonOpposite sex-biased eQTM regulation.
CpG SiteCpG PostionCpG IslandPosition to GeneMale EffectMale FDRFemale EffectFemale FDRMale CorMale P-valueFemale CorFemale P-valueSex-biased Coding GeneCancer Type

Top

Sex-biased sQTL regulation of gene

check buttonSex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).
sQTLDescription

check buttonMale-specific sQTL regulation.
ES IDSkipped ExonORF AnnoSNP IDSNP InfoSNP Position to ESEffect ScoreFDRCancer TypeBiased Type

check buttonFemale-specific sQTL regulation.
ES IDSkipped ExonORF AnnoSNP IDSNP InfoSNP Position to ESEffect ScoreFDRCancer TypeBiased Type

check buttonOpposite sex-biased sQTL regulation.
ES IDSkipped ExonORF AnnoSNP IDSNP InfoSNP Position to ESMale EffectMale FDRFemale EffectFemale FDRCancer Type

Top

Sex-biased sQTM regulation of gene

check buttonSex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).
sQTMDescription

check buttonMale-specific sQTM regulation.
EX IDSkipped ExonCPG SiteCPG PositionPosition to EX EventsEffect ScoreFDRCor.rCor.PvalueORF_annoCancer Type

check buttonFemale-specific sQTM regulation.
EX IDSkipped ExonCPG SiteCPG PositionPosition to EX EventsEffect ScoreFDRCor.rCor.PvalueORF_annoCancer Type

check buttonOpposite sex-biased sQTM regulation.
EX IDEX InfoSkipped ExonCPG SiteCPG PositionCPG IslandPosition to EX EventsMale EffectMale FDRFemale EffectFemale FDRMale CorrelationMale P-valueFemale CorrelationFemale P-valueORF_annoCancer Type

Top

Related disease information of VEGFA

check buttonDiseases associated with this gene (DisGeNET).
Gene IDGene SymbolDisease IDDisease NameNumber of PMIDSource
ENSG00000112715VEGFAC0001418Adenocarcinoma1CTD_human
ENSG00000112715VEGFAC0002152Alloxan Diabetes1CTD_human
ENSG00000112715VEGFAC0002395Alzheimer's Disease1CTD_human
ENSG00000112715VEGFAC0003865Arthritis, Adjuvant-Induced2CTD_human
ENSG00000112715VEGFAC0003873Rheumatoid Arthritis1CTD_human
ENSG00000112715VEGFAC0004096Asthma3CTD_human
ENSG00000112715VEGFAC0004153Atherosclerosis1CTD_human
ENSG00000112715VEGFAC0005586Bipolar Disorder2PSYGENET
ENSG00000112715VEGFAC0006118Brain Neoplasms1CTD_human
ENSG00000112715VEGFAC0006826Malignant Neoplasms1CTD_human
ENSG00000112715VEGFAC0007102Malignant tumor of colon1CTD_human
ENSG00000112715VEGFAC0007131Non-Small Cell Lung Carcinoma1CTD_human
ENSG00000112715VEGFAC0007137Squamous cell carcinoma2CTD_human
ENSG00000112715VEGFAC0007873Uterine Cervical Neoplasm1CTD_human
ENSG00000112715VEGFAC0008677Bronchitis, Chronic1CTD_human
ENSG00000112715VEGFAC0009375Colonic Neoplasms1CTD_human
ENSG00000112715VEGFAC0010054Coronary Arteriosclerosis2CTD_human
ENSG00000112715VEGFAC0010398Cruveilhier-Baumgarten Syndrome1CTD_human
ENSG00000112715VEGFAC0011265Presenile dementia1CTD_human
ENSG00000112715VEGFAC0011570Mental Depression5PSYGENET
ENSG00000112715VEGFAC0011581Depressive disorder5PSYGENET
ENSG00000112715VEGFAC0011616Contact Dermatitis1CTD_human
ENSG00000112715VEGFAC0011853Diabetes Mellitus, Experimental1CTD_human
ENSG00000112715VEGFAC0011881Diabetic Nephropathy1CTD_human
ENSG00000112715VEGFAC0011884Diabetic Retinopathy3CTD_human
ENSG00000112715VEGFAC0013366Dyschondroplasias1CTD_human
ENSG00000112715VEGFAC0014170Endometrial Neoplasms1CTD_human
ENSG00000112715VEGFAC0014556Epilepsy, Temporal Lobe1CTD_human
ENSG00000112715VEGFAC0014558Uncinate Epilepsy1CTD_human
ENSG00000112715VEGFAC0017636Glioblastoma1CTD_human
ENSG00000112715VEGFAC0017667Nodular glomerulosclerosis1CTD_human
ENSG00000112715VEGFAC0018671Head and Neck Neoplasms1CTD_human
ENSG00000112715VEGFAC0018675Head Neoplasms1CTD_human
ENSG00000112715VEGFAC0018798Congenital Heart Defects1CTD_human
ENSG00000112715VEGFAC0018799Heart Diseases1CTD_human
ENSG00000112715VEGFAC0018801Heart failure2CTD_human
ENSG00000112715VEGFAC0018802Congestive heart failure2CTD_human
ENSG00000112715VEGFAC0018923Hemangiosarcoma1CTD_human
ENSG00000112715VEGFAC0019193Hepatitis, Toxic1CTD_human
ENSG00000112715VEGFAC0020541Portal Hypertension1CTD_human
ENSG00000112715VEGFAC0021368Inflammation1CTD_human
ENSG00000112715VEGFAC0022660Kidney Failure, Acute2CTD_human
ENSG00000112715VEGFAC0023186Learning Disorders1CTD_human
ENSG00000112715VEGFAC0023212Left-Sided Heart Failure2CTD_human
ENSG00000112715VEGFAC0023466Leukemia, Monocytic, Chronic1CTD_human
ENSG00000112715VEGFAC0023470Myeloid Leukemia1CTD_human
ENSG00000112715VEGFAC0023890Liver Cirrhosis1CTD_human
ENSG00000112715VEGFAC0023893Liver Cirrhosis, Experimental2CTD_human
ENSG00000112715VEGFAC0024115Lung diseases1CTD_human
ENSG00000112715VEGFAC0024440Macular Edema, Cystoid1CTD_human
ENSG00000112715VEGFAC0025237Melnick-Needles Syndrome1CTD_human
ENSG00000112715VEGFAC0025261Memory Disorders1CTD_human
ENSG00000112715VEGFAC0026760Multiple Epiphyseal Dysplasia1CTD_human
ENSG00000112715VEGFAC0027055Myocardial Reperfusion Injury1CTD_human
ENSG00000112715VEGFAC0027533Neck Neoplasms1CTD_human
ENSG00000112715VEGFAC0027627Neoplasm Metastasis3CTD_human
ENSG00000112715VEGFAC0027643Neoplasm Recurrence, Local1CTD_human
ENSG00000112715VEGFAC0027651Neoplasms1CTD_human
ENSG00000112715VEGFAC0027659Neoplasms, Experimental3CTD_human
ENSG00000112715VEGFAC0027686Pathologic Neovascularization2CTD_human
ENSG00000112715VEGFAC0029422Osteochondrodysplasias1CTD_human
ENSG00000112715VEGFAC0029463Osteosarcoma1CTD_human
ENSG00000112715VEGFAC0030246Pustulosis of Palms and Soles1CTD_human
ENSG00000112715VEGFAC0032927Precancerous Conditions1CTD_human
ENSG00000112715VEGFAC0033578Prostatic Neoplasms4CTD_human
ENSG00000112715VEGFAC0033687Proteinuria1CTD_human
ENSG00000112715VEGFAC0033860Psoriasis1CTD_human
ENSG00000112715VEGFAC0035228Respiratory Hypersensitivity1CTD_human
ENSG00000112715VEGFAC0035309Retinal Diseases1CTD_human
ENSG00000112715VEGFAC0035328Retinal Vein Occlusion1CTD_human
ENSG00000112715VEGFAC0035412Rhabdomyosarcoma1CTD_human
ENSG00000112715VEGFAC0036391Schwartz-Jampel Syndrome1CTD_human
ENSG00000112715VEGFAC0038015Spondyloepiphyseal Dysplasia1CTD_human
ENSG00000112715VEGFAC0038220Status Epilepticus1CTD_human
ENSG00000112715VEGFAC0038358Gastric ulcer1CTD_human
ENSG00000112715VEGFAC0038433Streptozotocin Diabetes1CTD_human
ENSG00000112715VEGFAC0042076Urologic Neoplasms1CTD_human
ENSG00000112715VEGFAC0085109Corneal Neovascularization1CTD_human
ENSG00000112715VEGFAC0085605Liver Failure1CTD_human
ENSG00000112715VEGFAC0086692Benign Neoplasm1CTD_human
ENSG00000112715VEGFAC0151744Myocardial Ischemia5CTD_human
ENSG00000112715VEGFAC0153633Malignant neoplasm of brain1CTD_human
ENSG00000112715VEGFAC0162351Contact hypersensitivity1CTD_human
ENSG00000112715VEGFAC0178540Cerebral Hypoxia-Ischemia1CTD_human
ENSG00000112715VEGFAC0205641Adenocarcinoma, Basal Cell1CTD_human
ENSG00000112715VEGFAC0205642Adenocarcinoma, Oxyphilic1CTD_human
ENSG00000112715VEGFAC0205643Carcinoma, Cribriform1CTD_human
ENSG00000112715VEGFAC0205644Carcinoma, Granular Cell1CTD_human
ENSG00000112715VEGFAC0205645Adenocarcinoma, Tubular1CTD_human
ENSG00000112715VEGFAC0206726gliosarcoma1CTD_human
ENSG00000112715VEGFAC0233794Memory impairment1CTD_human
ENSG00000112715VEGFAC0235527Heart Failure, Right-Sided2CTD_human
ENSG00000112715VEGFAC0239946Fibrosis, Liver1CTD_human
ENSG00000112715VEGFAC0242350Erectile dysfunction1CTD_human
ENSG00000112715VEGFAC0242383Age related macular degeneration1CTD_human
ENSG00000112715VEGFAC0270823Petit mal status1CTD_human
ENSG00000112715VEGFAC0271051Macular retinal edema1CTD_human
ENSG00000112715VEGFAC0271178Irvine-Gass Syndrome1CTD_human
ENSG00000112715VEGFAC0276496Familial Alzheimer Disease (FAD)1CTD_human
ENSG00000112715VEGFAC0278996Malignant Head and Neck Neoplasm1CTD_human
ENSG00000112715VEGFAC0282313Condition, Preneoplastic1CTD_human
ENSG00000112715VEGFAC0311335Grand Mal Status Epilepticus1CTD_human
ENSG00000112715VEGFAC0334588Giant Cell Glioblastoma1CTD_human
ENSG00000112715VEGFAC0342257Complications of Diabetes Mellitus1CTD_human
ENSG00000112715VEGFAC0376358Malignant neoplasm of prostate4CTD_human
ENSG00000112715VEGFAC0393672Epilepsy, Benign Psychomotor, Childhood1CTD_human
ENSG00000112715VEGFAC0393682Epilepsy, Lateral Temporal1CTD_human
ENSG00000112715VEGFAC0393734Complex Partial Status Epilepticus1CTD_human
ENSG00000112715VEGFAC0432272Van Buchem disease1CTD_human
ENSG00000112715VEGFAC0476089Endometrial Carcinoma1CTD_human
ENSG00000112715VEGFAC0494463Alzheimer Disease, Late Onset1CTD_human
ENSG00000112715VEGFAC0496899Benign neoplasm of brain, unspecified1CTD_human
ENSG00000112715VEGFAC0525045Mood Disorders2PSYGENET
ENSG00000112715VEGFAC0546126Acute Confusional Senile Dementia1CTD_human
ENSG00000112715VEGFAC0600518Choroidal Neovascularization1CTD_human
ENSG00000112715VEGFAC0678807prenatal alcohol exposure1PSYGENET
ENSG00000112715VEGFAC0746787Cancer of Neck1CTD_human
ENSG00000112715VEGFAC0750900Alzheimer's Disease, Focal Onset1CTD_human
ENSG00000112715VEGFAC0750901Alzheimer Disease, Early Onset1CTD_human
ENSG00000112715VEGFAC0750974Brain Tumor, Primary1CTD_human
ENSG00000112715VEGFAC0750977Recurrent Brain Neoplasm1CTD_human
ENSG00000112715VEGFAC0750979Primary malignant neoplasm of brain1CTD_human
ENSG00000112715VEGFAC0751177Cancer of Head1CTD_human
ENSG00000112715VEGFAC0751262Adult Learning Disorders1CTD_human
ENSG00000112715VEGFAC0751263Learning Disturbance1CTD_human
ENSG00000112715VEGFAC0751265Learning Disabilities1CTD_human
ENSG00000112715VEGFAC0751292Age-Related Memory Disorders1CTD_human
ENSG00000112715VEGFAC0751293Memory Disorder, Semantic1CTD_human
ENSG00000112715VEGFAC0751294Memory Disorder, Spatial1CTD_human
ENSG00000112715VEGFAC0751295Memory Loss1CTD_human
ENSG00000112715VEGFAC0751522Status Epilepticus, Subclinical1CTD_human
ENSG00000112715VEGFAC0751523Non-Convulsive Status Epilepticus1CTD_human
ENSG00000112715VEGFAC0751524Simple Partial Status Epilepticus1CTD_human
ENSG00000112715VEGFAC0751571Cancer of Urinary Tract1CTD_human
ENSG00000112715VEGFAC0752304Hypoxic-Ischemic Encephalopathy1CTD_human
ENSG00000112715VEGFAC0752305Anoxic-Ischemic Encephalopathy1CTD_human
ENSG00000112715VEGFAC0752306Anoxia-Ischemia, Brain1CTD_human
ENSG00000112715VEGFAC0752307Anoxia-Ischemia, Cerebral1CTD_human
ENSG00000112715VEGFAC0752308Hypoxia-Ischemia, Brain1CTD_human
ENSG00000112715VEGFAC0860207Drug-Induced Liver Disease1CTD_human
ENSG00000112715VEGFAC0887833Carcinoma, Pancreatic Ductal1CTD_human
ENSG00000112715VEGFAC0887900Upper Aerodigestive Tract Neoplasms1CTD_human
ENSG00000112715VEGFAC0971858Arthritis, Collagen-Induced2CTD_human
ENSG00000112715VEGFAC0993582Arthritis, Experimental2CTD_human
ENSG00000112715VEGFAC1262760Hepatitis, Drug-Induced1CTD_human
ENSG00000112715VEGFAC1269683Major Depressive Disorder5PSYGENET
ENSG00000112715VEGFAC1330966Developmental Academic Disorder1CTD_human
ENSG00000112715VEGFAC1527390Neoplasms, Intracranial1CTD_human
ENSG00000112715VEGFAC1527411Thrombosis of retinal vein1CTD_human
ENSG00000112715VEGFAC1563937Atherogenesis1CTD_human
ENSG00000112715VEGFAC1565662Acute Kidney Insufficiency2CTD_human
ENSG00000112715VEGFAC1621958Glioblastoma Multiforme1CTD_human
ENSG00000112715VEGFAC1956346Coronary Artery Disease2CTD_human
ENSG00000112715VEGFAC1959583Myocardial Failure2CTD_human
ENSG00000112715VEGFAC1961112Heart Decompensation2CTD_human
ENSG00000112715VEGFAC2063866Depressive Disorder, Treatment-Resistant1PSYGENET
ENSG00000112715VEGFAC2609414Acute kidney injury2CTD_human
ENSG00000112715VEGFAC2676832MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1(finding)1CTD_human
ENSG00000112715VEGFAC2717961Thrombotic Microangiopathies1CTD_human
ENSG00000112715VEGFAC2931852Clear-cell metastatic renal cell carcinoma1CTD_human
ENSG00000112715VEGFAC2937358Cerebral Hemorrhage1CTD_human
ENSG00000112715VEGFAC3541456Spondyloepiphyseal Dysplasia Tarda, X-Linked1CTD_human
ENSG00000112715VEGFAC3658290Drug-Induced Acute Liver Injury1CTD_human
ENSG00000112715VEGFAC4048328cervical cancer1CTD_human
ENSG00000112715VEGFAC4277682Chemical and Drug Induced Liver Injury1CTD_human
ENSG00000112715VEGFAC4279912Chemically-Induced Liver Toxicity1CTD_human
ENSG00000112715VEGFAC4551479Schwartz-Jampel Syndrome, Type 11CTD_human